ETFChannel.com
VYGR Description — Voyager Therapeutics Inc

Voyager Therapeutics is a gene therapy company focused on developing treatments and platform technologies. Co.'s team has developed a proprietary adeno-associated virus (AAV) capsid discovery platform called TRACER™ (Tropism Redirection of AAV by Cell Type-Specific Expression of RNA) to facilitate the selection of AAV capsids with blood brain barrier crossing and cell-specific transduction properties for particular therapeutic applications. The TRACER discovery platform is a functional RNA-based AAV capsid discovery platform that allows for rapid in vivo evolution of AAV capsids with cell-specific transduction properties in multiple species, including non-human primates.

Company Name: 
Voyager Therapeutics Inc
Website: 
www.voyagertherapeutics.com
Sector: 
Biotechnology
Number of ETFs Holding VYGR: 
5
Total Market Value Held by ETFs: 
$7,937,950
Total Market Capitalization: 
$229,000,000
% of Market Cap. Held by ETFs: 
3.47%
 ETF   VYGR Weight   VYGR Amount 
 VTI   0.00%   $5,285,271         
 VXF   0.00%   $2,131,899         
 IWC   0.04%   $331,026         
 ITOT   0.00%   $165,557         
 QQQS   0.51%   $24,197         
Quotes delayed 20 minutes

Email EnvelopeFree VYGR Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Hold (2.50 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts Forecast:
VYGR Price Target

Based on data provided by Zacks Investment Research via Quandl.com

ETFs Holding VYGR | Voyager Therapeutics Inc | ETF Channel | www.ETFChannel.com

Copyright © 2010 - 2022, All Rights Reserved Nothing in ETF Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and ETF videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact ETF Channel; Meet Our Editorial Staff.